What are capillary blood ketone levels in type 1 diabetic patients using CSII in normal conditions of insulin delivery?

Diabetes and Metabolism

Volumn 30, Issue 6, 2004, Pages 543-547

  Matta, M P ^a   Melki, V ^a   Bessiere Lacombe S ^a   Hanaire Broutin, H ^a  

^a CHU RANGUEIL   (France)

Author keywords

Capillary ketonemia; CSII; Ketoacidosis

Indexed keywords

3 HYDROXYBUTYRIC ACID; GLUCOSE; HUMALOG U100; INSULIN LISPRO; KETONE; UNCLASSIFIED DRUG;

ADULT; ANALYTICAL EQUIPMENT; ARTICLE; CAPILLARY BLOOD; CONTINUOUS INFUSION; DRUG DELIVERY SYSTEM; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; KETOACIDOSIS; KETONURIA; MAJOR CLINICAL STUDY; MALE; QUANTITATIVE ANALYSIS; SELF MONITORING;

EID: 11244299468     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70153-2     Document Type: Article

References (25)

1. Diabetes Control and Complications Trial Research Group. the effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus: the Diabetes Control and Complications Trial Research group. N Engl J Med, 1993, 329, 977-86.
2. Diabetes Control and Complications Trial Research Group. Implementation of treatment protocols in the Diabetes Control and Complications Trial. Diabetes care, 1995, 18, 361-76.
3. Egger M, Davey Smith G, Stettler C, Diem P. Risk of adverse effects of intensified treatment in insulin-dependent diabetes mellitus: a meta-analysis. Diabet Med, 1997, 14, 919-28.
4. Reichel A, Rietzsch H, Kohler HI, Pfutzner A, Gudat U, Schulze J. Cessation of insulin infusion at night-time during CSII therapy: comparison of regular human insulin and insulin lispro. Exp Clin Endocrinol Diabetes, 1998, 106, 168-72.
5. Pein M, Hinselmann C, Pfutzner A, Dreyer M. Catheter disconnection in type I diabetic patients treated with CSII: Comparison of insulin lispro and human regular insulin. Diabetologia, 1996, 39, 847.
6. Wiklund G, Taube GM. Adolescents with type I diabetes prefer ketone testing in blood. Diabetes, 2003, (Abstract) 52, A565.
7. Laffel L. Ketone bodies: a review of physiology, pathophysiology and application of monitoring of diabetes. Diabetes Metab Rev, 1999, 15, 412-26.
8. Prisco F, Iafusco D, Lorini R, et al. Usefulness of ketone bodies for monitoring insulin therapy in patients with recent onset type I diabetes (A multicenter study). Diabetes, 2003, (Abstract) 52, A131.
9. Byrne HA, Tieczen KL, Hollis S, Dornan T, New J. Evaluation of an electrochemical sensor for measuring blood ketones. Diabetes Care, 2000, 23, 500-3.
10. Guerci B, Benichou M, Floriot M, et al. Accuracy of an electrochemical sensor for measuring capillary blood ketones by fingerstick samples during metabolic deterioration after continuous subcutaneous insulin infusion interruption in type I diabetic patients. Diabetes Care, 2003, 26, 1137-41.
11. Ubukata E. Diurnal variation of blood ketone bodies in insulin-dependent diabetes mellitus and noninsulin-dependent diabetes mellitus patients: the relationship to serum C-peptide immunoreactivity and free insulin. Ann Nutr Metab, 1990, 34, 333-42.
12. Bruttomesso D, Pianta A, Crazzolara D, et al. Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy, acceptability and quality of life. Diabet Med, 2001, 19, 628-34.
13. Linkeschova R, Raoul M, Bott U, Berger M, Spraul M. Less severe hypoglycaemia, better metabolic control, and improved quality of life in type I diabetes mellitus with continuous subcutaneous insulin infusion(CSII) therapy: an observational study of 100 consecutive patients followed foe a mean of 2 years. Diabet Med, 2002, 19, 746-51.
14. DeVries JH, Snoek FJ, Kostense PJ, Masurel N, Heine RJ; Dutch Insulin Pump Study Group. A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type I diabetes for patients with long-standing poor glycemic control. Diabetes Care, 2002, 25, 2074-80.
15. Hanaire-Broutin H, Melki V, Bessieres-Lacombe, S, Tauber JP. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type I diabetic patients on intensified treatment: a randomized study: The Study Group for the Development of Pump Therapy in Diabetes. Diabetes Care, 2000, 23, 1232-5.
16. Guerci B, Meyer L, Salla A, et al. Comparison of metabolic deterioration between insulin analog and regular insulin after a 5 hour interruption of a continuous subcutaneous insulin infusion in type I diabetic patients. J Clin Endocrinol Metab, 1999, 84, 2673-8.
17. Peden NR, Braaten JT, McKendry JB. Diabetic ketoacidosis during long-term treatment with continuous subcutaneous insulin infusion. Diabetes Care, 1984, 7, 1-5.
18. Pickup JC, Sherwin RS, Tamborlane WV, Rizza RA, Service FJ. Conference in insulin pump therapy in diabetes. Multicenter study of effect on microvascular disease. The pump life. Patients responses and clinical and technological problems. Diabetes, 1985, 34, 37-41.
19. Mecklenburg RS, Benson EA, Benson JW Jr, et al. Acute complications asociated with insulin infusion pump therapy. Report of experience with 161 patients. JAMA, 1984, 252, 3265-9.
20. Mitchell GA, Kassovska-Bratinova S, Boukaftane Y, et al. Medical aspects of ketone body metabolism. Clin Invest Med, 1995, 1, 193-216.
21. Jenkins D, Close CF, Krentz AJ, Nattrass M, Wright AD. Euglycemic diabetic ketoacidosis: does it exist? Acta Diabetologica, 1993, 30, 251-3.
22. Clark JD, McConnell A, Hartog M. Normoglycemic ketoacidosis in a woman with gestational diabetes. Diabet Med, 1991, 8, 388-9.
23. Cullen MT, Reece EA, Homko CJ, Sivan E. The changing presentations of diabetic ketoacidosis during pregnancy. Am J Perinatol, 1996, 13, 449-51.
24. Burge MR, Hardy KJ, Schade DS. Short-term fasting is a mechanism H. for the development of euglycemic ketoacidosis during periods of insulin deficiency. J Clin Endocrinol Metab, 1993, 76, 1192-8.
25. Krzentowski G, Scheen A, Castillo M, Luyckx AS, Lefebvre PJ. A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: Metabolic and hormonal consequences and scheme for a prompt return to adequate control. Diabetologia, 1983, 24, 314-8.